Featured cGMP therapeutic peptides supplied to Singaporean pharmaceutical hubs, clinical research centers, and global formulation developers.
Glucagon-like peptide-1 (GLP-1) receptor agonist produced via recombinant DNA or advanced solid-phase peptide synthesis for metabolic disorder management in Singapore clinical networks.
View Product Details
Synthetic vasopressin analogue engineered for high biological activity, low moisture content, and stringent purity standard compliant with HSA & FDA regulatory frameworks.
View Product Details
Cyclic heptapeptide platelet aggregation inhibitor manufactured under strict batch-to-batch consistency for critical cardiovascular therapeutic applications.
View Product Details
Vasoactive synthetic peptide prodrug designed for high stability, controlled impurity profiles, and rapid integration into sterile injectable formulations.
View Product DetailsAn in-depth analysis of Singapore's positioning as Asia-Pacific's premier biopharmaceutical commercialization hub and supply node.
Singapore has established itself as an indispensable biopharmaceutical nexus within the Asia-Pacific region. Home to world-class industrial hubs such as the Tuas Biomedical Park and the Biopolis research ecosystem, the nation hosts leading multinational pharmaceutical corporations, contract development and manufacturing organizations (CDMOs), and cutting-edge translational research institutes.
The demand for high-purity Active Pharmaceutical Ingredients (APIs), particularly complex synthetic peptides and therapeutic oligopeptides, has experienced exponential growth across Singapore. Local research institutes, hospital networks, and regional formulation plants rely heavily on robust, cGMP-compliant global supply chains to fuel clinical trials, regional commercial distribution, and advanced drug delivery innovation.
Singaporean drug developers require ultra-pure APIs with stringent controls over elemental impurities, residual solvents, and enantiomeric purity. Suppliers must provide robust US DMF, CEP, or HSA documentation.
Peptide active ingredients demand strict cold-chain integrity (-20°C to 4°C storage). Singapore’s advanced airport infrastructure provides seamless temperature-monitored transit across SEA markets.
Local contract formulators collaborate with established peptide manufacturers to develop long-acting depot injections, sublingual tablets, and novel transdermal peptide patches.
Navigating Solid-Phase Synthesis (SPPS), Liquid-Phase Synthesis (LPPS), and Green Chemistry Transformations.
Modern peptide manufacturing relies heavily on Solid-Phase Peptide Synthesis (SPPS) using Fmoc/tBu chemistry strategies. For long-chain peptides like GLP-1 analogues (Semaglutide, Liraglutide, Tirzepatide), hybrid synthesis approaches—combining solid-phase fragment coupling with liquid-phase condensation—ensure high overall yields and minimize deletion sequences.
State-of-the-art automated peptide synthesizers equipped with real-time UV monitoring and microwave-assisted couplings enable precise control over sterically hindered amino acid additions, resulting in superior crude purity before preparative HPLC purification.
Quality assurance for peptide APIs demands rigorous multi-tiered analytical testing. Ultra-Performance Liquid Chromatography (UPLC) paired with High-Resolution Mass Spectrometry (HRMS) confirms molecular weight and sequence integrity.
Key parameters evaluated include mass balance, trifluoroacetic acid (TFA) or acetate counterion content, heavy metal residue (ICP-MS), bacterial endotoxin levels, and bioburden testing, guaranteeing safety for injectable formulation development in Singapore and worldwide.
Unlocking substantial cost synergies, rapid batch scalability, and raw material self-sufficiency for global pharmaceutical purchasers.
Chinese peptide manufacturing complexes benefit from complete upstream integration, producing protected amino acids, resins, and coupling reagents in-house. This mitigates raw material price volatility and guarantees uninterrupted batch delivery schedules for Singaporean partners.
With multi-ton reactor capacities and multi-thousand-square-meter standard cGMP industrial bases, Chinese factories achieve economies of scale impossible in smaller markets. Cost reductions of 30% to 50% are regularly realized without sacrificing compliance or purity.
From milligram-scale R&D pilot batches to multi-kilogram commercial production runs, Chinese manufacturing infrastructure offers flexible tech-transfer workflows, allowing fast-track progress from preclinical phases to commercial market release in Singapore.
End-to-end B2B solutions tailored for biopharmaceutical innovators, generic medicine producers, and research labs.
Our main services focus on supplying Peptides APIs and Custom Peptides, FDF License Out, Technical Support & Consultation, Product Line and Lab Setup, Sourcing & Supply Chain Solutions.
An overall factory construction area of 250,000 square meters under international standard to offer flexible, scalable and cost-effective solutions for raw materials and advanced chemical synthesis.
Gentolex offers an extensive range of APIs and intermediates for development study and commercial application with cGMP standard from long-term collaborations. Documents and Certificates are supported to customers worldwide.
Custom synthesis pathways, process optimization, impurity profiling, and analytical method validation for specialized peptide entities and therapeutic clinical trials.
For those clients who prefer to avoid the complexity of dealing with multiple points of contact, we provide extra customized procurement services with the most superior and comprehensive supply chain sources.
Gentolex’s goal is to create opportunities connecting the world with better services and guaranteed products. Up to date, Gentolex Group has been serving customers from more than 10 countries, specially, representatives are established in Mexico and South Africa.
Our main services focus on supplying peptides APIs and Custom Peptides, FDF license out, Technical Support & Consultation, Product Line and Lab Setup, Sourcing & Supply Chain Solutions.
Exploring therapeutic innovations in metabolic care, oncology conjugates, and oral peptide delivery systems across Southeast Asia.
Driven by Singapore's national healthcare initiatives targeting diabetes and obesity, demand for Semaglutide, Liraglutide, Tirzepatide, and Cagrilintide APIs has skyrocketed. Procurement focuses on long-term stability and high-purity batch reproducibility.
As targeted cancer therapeutics advance in Singapore research institutions, peptide ligands are increasingly synthesized to act as delivery vehicles for cytotoxic payloads, opening new requirements for custom peptide linkage chemistry.
Overcoming enzymatic degradation in the gastrointestinal tract is a primary goal. Manufacturers partner with Singapore formulators using permeation enhancers (e.g., SNAC) to convert traditionally injectable APIs into oral dosage forms.
Explore our full range of high-purity active pharmaceutical ingredients available for bulk order and regulatory license-out in Singapore.
Recombinant parathyroid hormone fragment (PTH 1-34) designed to stimulate bone formation with high specific activity.
View Product Details
Synthetic nonapeptide oxytocin/vasopressin antagonist utilized in obstetric care for inhibiting spontaneous preterm labor.
View Product Details
Long-acting synthetic octapeptide analogue of oxytocin manufactured for severe hemorrhage prevention formulations.
View Product Details
Synthetic decapeptide GnRH antagonist used in controlled ovarian stimulation programs within reproductive health protocols.
View Product Details
High-purity GnRH antagonist controlling luteinizing hormone surge with strict enantiomeric standard and reliable shelf-life.
View Product Details
Guanylate cyclase-C agonist 14-amino acid synthetic peptide with triple disulfide bridges for gastrointestinal therapies.
View Product Details
GLP-1 receptor agonist peptide engineered for extended plasma half-life through fatty acid side-chain conjugation.
View Product Details
Synthetic nonapeptide GnRH agonist for prostate cancer, endometriosis, and hormone regulation protocols.
View Product Details
Ultra-pure commercial scale Semaglutide synthetic raw material meeting stringent global pharmacopeial standards.
View Product Details
Dual GIP and GLP-1 receptor agonist peptide API manufactured with precision side-chain lipidation chemistry.
View Product Details
Synthetic D-amino acid peptide calcimimetic agent for treating secondary hyperparathyroidism in chronic kidney disease.
View Product Details
Investigational long-acting amylin analogue API designed for combination metabolic and weight management therapies.
View Product DetailsStay updated with our latest research whitepapers, peptide API analysis, and active substance manufacturing innovations.
Selank Acetate API is a synthetic heptapeptide active pharmaceutical ingredient composed of the amino acid sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro (TKPRPGP). Originally developed through neuropharmacological research, Selank is a derivative of the endogenous neuro-active sequence...
View Details
As a professional Thymosin Beta-4 API manufacturer and supplier, we provide high-quality Thymosin Beta-4 peptide API solutions for biotechnology companies, pharmaceutical research organizations, and commercial laboratories needing compliant bulk materials...
View Details
BPC-157 API is a synthetic pentadecapeptide that has gained increasing attention in peptide research due to its potential biological activities related to tissue repair, gastrointestinal protection, angiogenesis, and inflammatory regulation pathways...
View Details
With the continuous development of neuroscience, peptide technology, and life science research, neuroactive peptides have become an important area of scientific investigation. Semax, a synthetic peptide derived from an ACTH fragment...
View Details
SS-31 API, also known as Elamipretide, MTP-131, Bendavia, and SS31, is a synthetic mitochondria-targeting tetrapeptide designed to bind cardiolipin in the inner mitochondrial membrane, stabilizing cellular bioenergetics...
View DetailsAddressing regulatory, quality, and commercial inquiries for peptide API sourcing in Singapore and international markets.
Looking for reliable bulk supply, technical DMF support, or custom synthesis for Singapore and global biopharmaceutical markets? Reach out to our technical sales team for immediate quotation and specification support.
Send Inquiry Now
